{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T09:59:09Z","timestamp":1792835949984,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171423"],"award-info":[{"award-number":["82171423"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060211"],"award-info":[{"award-number":["82060211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460263"],"award-info":[{"award-number":["82460263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31530089"],"award-info":[{"award-number":["31530089"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anyu Biopharmaceutics, Inc., Hangzhou"},{"DOI":"10.13039\/100017957","name":"Guizhou Provincial Health Commission","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41380-024-02837-6","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T18:53:30Z","timestamp":1731956010000},"page":"2316-2334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage"],"prefix":"10.1038","volume":"30","author":[{"given":"Jiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2713-9136","authenticated-orcid":false,"given":"Song","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanbin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Hui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5048-8134","authenticated-orcid":false,"given":"Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-8596","authenticated-orcid":false,"given":"Jun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"2837_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrn.2017.29","volume":"18","author":"UC Muller","year":"2017","unstructured":"Muller UC, Deller T, Korte M. Not just amyloid: physiological functions of the amyloid precursor protein family. Nat Rev Neurosci. 2017;18:281\u201398.","journal-title":"Nat Rev Neurosci"},{"key":"2837_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42822-1","volume":"14","author":"V Nithianandam","year":"2023","unstructured":"Nithianandam V, Bukhari H, Leventhal MJ, Battaglia RA, Dong X, Fraenkel E, et al. Integrative analysis reveals a conserved role for the amyloid precursor protein in proteostasis during aging. Nat Commun. 2023;14:7034.","journal-title":"Nat Commun"},{"key":"2837_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pneurobio.2008.05.002","volume":"85","author":"T Muller","year":"2008","unstructured":"Muller T, Meyer HE, Egensperger R, Marcus K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics-relevance for Alzheimer\u2019s disease. Prog Neurobiol. 2008;85:393\u2013406.","journal-title":"Prog Neurobiol"},{"key":"2837_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733\u20136.","journal-title":"Nature"},{"key":"2837_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.tips.2016.01.005","volume":"37","author":"C Deyts","year":"2016","unstructured":"Deyts C, Thinakaran G, Parent AT. APP receptor? to be or not to be. Trends Pharmacol Sci. 2016;37:390\u2013411.","journal-title":"Trends Pharmacol Sci"},{"key":"2837_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12035-020-02139-2","volume":"58","author":"JF da Rocha","year":"2021","unstructured":"da Rocha JF, Bastos L, Domingues SC, Bento AR, Konietzko U, da Cruz ESOAB, et al. APP binds to the EGFR ligands HB-EGF and EGF, acting synergistically with EGF to promote ERK signaling and neuritogenesis. Mol Neurobiol. 2021;58:668\u201388.","journal-title":"Mol Neurobiol"},{"key":"2837_CR7","doi-asserted-by":"publisher","first-page":"e69199","DOI":"10.7554\/eLife.69199","volume":"10","author":"T Liu","year":"2021","unstructured":"Liu T, Zhang T, Nicolas M, Boussicault L, Rice H, Soldano A, et al. The amyloid precursor protein is a conserved Wnt receptor. Elife. 2021;10:e69199.","journal-title":"Elife"},{"key":"2837_CR8","doi-asserted-by":"publisher","first-page":"13892","DOI":"10.1016\/S0021-9258(19)57838-3","volume":"273","author":"S Hass","year":"1998","unstructured":"Hass S, Fresser F, Beyreuther KochlS, Utermann K, Baier G. Physical interaction of ApoE with amyloid precursor protein independent of the amyloid Abeta region in vitro. J Biol Chem. 1998;273:13892\u20137.","journal-title":"J Biol Chem"},{"key":"2837_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biopsych.2019.04.026","volume":"86","author":"D Sawmiller","year":"2019","unstructured":"Sawmiller D, Habib A, Hou H, Mori T, Fan A, Tian J, et al. A novel apolipoprotein E antagonist functionally blocks apolipoprotein E interaction with N-terminal amyloid precursor protein, reduces beta-amyloid-associated pathology, and improves cognition. Biol Psychiatry. 2019;86:208\u201320.","journal-title":"Biol Psychiatry"},{"key":"2837_CR10","doi-asserted-by":"publisher","first-page":"e26991","DOI":"10.7554\/eLife.26991","volume":"6","author":"D Puzzo","year":"2017","unstructured":"Puzzo D, Piacentini R, Fa M, Gulisano W, Li Puma DD, Staniszewski A, et al. LTP and memory impairment caused by extracellular Abeta and Tau oligomers is APP-dependent. Elife. 2017;6:e26991.","journal-title":"Elife"},{"key":"2837_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00018-023-04774-z","volume":"80","author":"J Chen","year":"2023","unstructured":"Chen J, Fan A, Li S, Xiao Y, Fu Y, Chen JS, et al. APP mediates tau uptake and its overexpression leads to the exacerbated tau pathology. Cell Mol Life Sci. 2023;80:123.","journal-title":"Cell Mol Life Sci"},{"key":"2837_CR12","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.3390\/ijms21093270","volume":"21","author":"R Maron","year":"2020","unstructured":"Maron R, Armony G, Tsoory M, Wilchek M, Frenkel D, Arnon R. Peptide interference with APP and Tau association: relevance to Alzheimer\u2019s Disease amelioration. Int J Mol Sci. 2020;21:3270.","journal-title":"Int J Mol Sci"},{"key":"2837_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jocn.2019.11.009","volume":"72","author":"Y Ohta","year":"2020","unstructured":"Ohta Y, Hishikawa N, Ikegami K, Sato K, Osakada Y, Takemoto M, et al. Different clinical and neuroimaging features of Japanese dementia siblings with a new N-terminal mutation (Val225Ala) of APP gene. J Clin Neurosci. 2020;72:482\u20134.","journal-title":"J Clin Neurosci"},{"key":"2837_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16580-3","volume":"11","author":"NM Kanaan","year":"2020","unstructured":"Kanaan NM, Hamel C, Grabinski T, Combs B. Liquid-liquid phase separation induces pathogenic tau conformations in vitro. Nat Commun. 2020;11:2809.","journal-title":"Nat Commun"},{"key":"2837_CR15","doi-asserted-by":"publisher","first-page":"e98049","DOI":"10.15252\/embj.201798049","volume":"37","author":"S Wegmann","year":"2018","unstructured":"Wegmann S, Eftekharzadeh B, Tepper K, Zoltowska KM, Bennett RE, Dujardin S, et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018;37:e98049.","journal-title":"EMBO J"},{"key":"2837_CR16","doi-asserted-by":"publisher","first-page":"31882","DOI":"10.1073\/pnas.2012460117","volume":"117","author":"S Boyko","year":"2020","unstructured":"Boyko S, Surewicz K, Surewicz WK. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation. Proc Natl Acad Sci USA. 2020;117:31882\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2837_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2020.103562","volume":"109","author":"CM Crosta","year":"2020","unstructured":"Crosta CM, Hernandez K, Bhattiprolu AK, Fu AY, Moore JC, Clarke SG, et al. Characterization hiPSC-derived neural progenitor cells and neurons to investigate the role of NOS1AP isoforms in human neuron dendritogenesis. Mol Cell Neurosci. 2020;109:103562.","journal-title":"Mol Cell Neurosci"},{"key":"2837_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02330-5","volume":"8","author":"GE Hoffman","year":"2017","unstructured":"Hoffman GE, Hartley BJ, Flaherty E, Ladran I, Gochman P, Ruderfer DM, et al. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains. Nat Commun. 2017;8:2225.","journal-title":"Nat Commun"},{"key":"2837_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ng0892-345","volume":"1","author":"M Mullan","year":"1992","unstructured":"Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet. 1992;1:345\u20137.","journal-title":"Nat Genet"},{"key":"2837_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1212\/01.WNL.0000042088.22694.E3","volume":"60","author":"JC Janssen","year":"2003","unstructured":"Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, Harvey RJ, et al. Early onset familial Alzheimer\u2019s disease: mutation frequency in 31 families. Neurology. 2003;60:235\u20139.","journal-title":"Neurology"},{"key":"2837_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349:704\u20136.","journal-title":"Nature"},{"key":"2837_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488:96\u20139.","journal-title":"Nature"},{"key":"2837_CR23","doi-asserted-by":"publisher","first-page":"e20210313","DOI":"10.1084\/jem.20210313","volume":"218","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang CM, Prokopenko D, Liang Y, Zhen SY, Weigle IQ, et al. An APP ectodomain mutation outside of the Abeta domain promotes Abeta production in vitro and deposition in vivo. J Exp Med. 2021;218:e20210313.","journal-title":"J Exp Med"},{"key":"2837_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s11064-019-02747-y","volume":"44","author":"A Tsatsanis","year":"2019","unstructured":"Tsatsanis A, Dickens S, Kwok JCF, Wong BX, Duce JA. Post translational modulation of beta-amyloid precursor protein trafficking to the cell surface alters neuronal iron homeostasis. Neurochem Res. 2019;44:1367\u201374.","journal-title":"Neurochem Res"},{"key":"2837_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"2837_CR26","doi-asserted-by":"publisher","first-page":"e80706","DOI":"10.1371\/journal.pone.0080706","volume":"8","author":"Q Guo","year":"2013","unstructured":"Guo Q, Li H, Cole AL, Hur JY, Li Y, Zheng H. Modeling Alzheimer\u2019s disease in mouse without mutant protein overexpression: cooperative and independent effects of Abeta and tau. PLoS One. 2013;8:e80706.","journal-title":"PLoS One"},{"key":"2837_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40478-015-0199-x","volume":"3","author":"AM Pooler","year":"2015","unstructured":"Pooler AM, Polydoro M, Maury EA, Nicholls SB, Reddy SM, Wegmann S, et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer\u2019s disease. Acta Neuropathol Commun. 2015;3:14.","journal-title":"Acta Neuropathol Commun"},{"key":"2837_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nm0495-365","volume":"1","author":"MA Smith","year":"1995","unstructured":"Smith MA, Siedlak SL, Richey PL, Mulvihill P, Ghiso J, Frangione B, et al. Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer\u2019s disease. Nat Med. 1995;1:365\u20139.","journal-title":"Nat Med"},{"key":"2837_CR29","first-page":"79","volume":"148","author":"G Giaccone","year":"1996","unstructured":"Giaccone G, Pedrotti B, Migheli A, Verga L, Perez J, Racagni G, et al. beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Am J Pathol. 1996;148:79\u201387.","journal-title":"Am J Pathol"},{"key":"2837_CR30","first-page":"265","volume":"151","author":"K Islam","year":"1997","unstructured":"Islam K, Levy E. Carboxyl-terminal fragments of beta-amyloid precursor protein bind to microtubules and the associated protein tau. Am J Pathol. 1997;151:265\u201371.","journal-title":"Am J Pathol"},{"key":"2837_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00401-015-1415-2","volume":"129","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Miyata H, Kametani F, Nonaka T, Akiyama H, Hisanaga S, et al. Extracellular association of APP and tau fibrils induces intracellular aggregate formation of tau. Acta Neuropathol. 2015;129:895\u2013907.","journal-title":"Acta Neuropathol"},{"key":"2837_CR32","doi-asserted-by":"publisher","first-page":"e202004062","DOI":"10.1083\/jcb.202004062","volume":"219","author":"NN Noda","year":"2020","unstructured":"Noda NN, Wang Z, Zhang H. Liquid-liquid phase separation in autophagy. J Cell Biol. 2020;219:e202004062.","journal-title":"J Cell Biol"},{"key":"2837_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00480-0","volume":"8","author":"S Ambadipudi","year":"2017","unstructured":"Ambadipudi S, Biernat J, Riedel D, Mandelkow E, Zweckstetter M. Liquid-liquid phase separation of the microtubule-binding repeats of the Alzheimer-related protein Tau. Nat Commun. 2017;8:275.","journal-title":"Nat Commun"},{"key":"2837_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106011","volume":"178","author":"H Ainani","year":"2023","unstructured":"Ainani H, Bouchmaa N, Ben Mrid R, El Fatimy R. Liquid-liquid phase separation of protein tau: An emerging process in Alzheimer\u2019s disease pathogenesis. Neurobiol Dis. 2023;178:106011.","journal-title":"Neurobiol Dis"},{"key":"2837_CR35","doi-asserted-by":"publisher","first-page":"9207","DOI":"10.3390\/ijms22179207","volume":"22","author":"J Sinsky","year":"2021","unstructured":"Sinsky J, Pichlerova K, Hanes J. Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 2021;22:9207.","journal-title":"Int J Mol Sci"},{"key":"2837_CR36","doi-asserted-by":"publisher","first-page":"12841","DOI":"10.3390\/ijms232112841","volume":"23","author":"P Rawat","year":"2022","unstructured":"Rawat P, Sehar U, Bisht J, Selman A, Culberson J, Reddy PH. Phosphorylated Tau in Alzheimer\u2019s disease and other tauopathies. Int J Mol Sci. 2022;23:12841.","journal-title":"Int J Mol Sci"},{"key":"2837_CR37","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nature02265","volume":"426","author":"FE Cohen","year":"2003","unstructured":"Cohen FE, Kelly JW. Therapeutic approaches to protein-misfolding diseases. Nature. 2003;426:905\u20139.","journal-title":"Nature"},{"key":"2837_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/science.add6696","volume":"381","author":"ZY Zhang","year":"2023","unstructured":"Zhang ZY, Harischandra DS, Wang R, Ghaisas S, Zhao JY, McMonagle TP, et al. TRIM11 protects against tauopathies and is down-regulated in Alzheimer\u2019s disease. Science. 2023;381:eadd6696.","journal-title":"Science"},{"key":"2837_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1039\/D1CS00127B","volume":"51","author":"G Limorenko","year":"2022","unstructured":"Limorenko G, Lashuel HA. Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies. Chem Soc Rev. 2022;51:513\u201365.","journal-title":"Chem Soc Rev"},{"key":"2837_CR40","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/01.HYP.21.6.810","volume":"21","author":"CM Erley","year":"1993","unstructured":"Erley CM, Haefele U, Heyne N, Braun N, Risler T. Microalbuminuria in essential hypertension. Reduction by different antihypertensive drugs. Hypertension. 1993;21:810\u20135. (6 Pt 1)","journal-title":"Hypertension"},{"key":"2837_CR41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","volume":"6","author":"C Borgo","year":"2021","unstructured":"Borgo C, D\u2019Amore C, Sarno S, Salvi M, Ruzzene M. Protein kinase CK2: a potential therapeutic target for diverse human diseases. Signal Transduct Target Ther. 2021;6:183.","journal-title":"Signal Transduct Target Ther"},{"key":"2837_CR42","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3233\/JAD-200721","volume":"77","author":"TT Quach","year":"2020","unstructured":"Quach TT, Moutal A, Khanna R, Deems NP, Duchemin AM, Barrientos RM. Collapsin response mediator proteins: novel targets for Alzheimer\u2019s disease. J Alzheimers Dis. 2020;77:949\u201360.","journal-title":"J Alzheimers Dis"},{"key":"2837_CR43","doi-asserted-by":"publisher","first-page":"mjac063","DOI":"10.1093\/jmcb\/mjac063","volume":"14","author":"Y Shen","year":"2023","unstructured":"Shen Y, Gu HM, Qin S, Zhang DW. Surf4, cargo trafficking, lipid metabolism, and therapeutic implications. J Mol Cell Biol. 2023;14:mjac063.","journal-title":"J Mol Cell Biol"},{"key":"2837_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf6232","volume":"9","author":"Z Wang","year":"2023","unstructured":"Wang Z, Patel VN, Song X, Xu Y, Kaminski AM, Doan VU, et al. Increased 3-O-sulfated heparan sulfate in Alzheimer\u2019s disease brain is associated with genetic risk gene HS3ST1. Sci Adv. 2023;9:eadf6232.","journal-title":"Sci Adv"},{"key":"2837_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mcn.2015.03.016","volume":"68","author":"B Calabrese","year":"2015","unstructured":"Calabrese B, Halpain S. Differential targeting of dynamin-1 and dynamin-3 to nerve terminals during chronic suppression of neuronal activity. Mol Cell Neurosci. 2015;68:36\u201345.","journal-title":"Mol Cell Neurosci"},{"key":"2837_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101222","volume":"297","author":"B Dai","year":"2021","unstructured":"Dai B, Zhong T, Chen ZX, Chen W, Zhang N, Liu XL, et al. Myricetin slows liquid-liquid phase separation of Tau and activates ATG5-dependent autophagy to suppress Tau toxicity. J Biol Chem. 2021;297:101222.","journal-title":"J Biol Chem"},{"key":"2837_CR47","doi-asserted-by":"publisher","first-page":"e202203102","DOI":"10.1083\/jcb.202203102","volume":"221","author":"T Ohshima","year":"2022","unstructured":"Ohshima T, Yamamoto H, Sakamaki Y, Saito C, Mizushima N. NCOA4 drives ferritin phase separation to facilitate macroferritinophagy and microferritinophagy. J Cell Biol. 2022;221:e202203102.","journal-title":"J Cell Biol"},{"key":"2837_CR48","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self WK, Holtzman DM. Emerging diagnostics and therapeutics for Alzheimer disease. Nat Med. 2023;29:2187\u201399.","journal-title":"Nat Med"},{"key":"2837_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.4103\/1673-5374.332125","volume":"17","author":"AK Torres","year":"2022","unstructured":"Torres AK, Rivera BI, Polanco CM, Jara C, Tapia-Rojas C. Phosphorylated tau as a toxic agent in synaptic mitochondria: implications in aging and Alzheimer\u2019s disease. Neural Regen Res. 2022;17:1645\u201351.","journal-title":"Neural Regen Res"},{"key":"2837_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2023","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in Alzheimer disease. Nat Rev Neurol. 2023;19:19\u201338.","journal-title":"Nat Rev Neurol"},{"key":"2837_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17:5\u201321.","journal-title":"Nat Rev Neurosci"},{"key":"2837_CR52","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.ajpath.2012.06.033","volume":"181","author":"HC Tai","year":"2012","unstructured":"Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012;181:1426\u201335.","journal-title":"Am J Pathol"},{"key":"2837_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1073858416633439","volume":"23","author":"P Regan","year":"2017","unstructured":"Regan P, Whitcomb DJ, Cho K. Physiological and pathophysiological implications of synaptic tau. Neuroscientist. 2017;23:137\u201351.","journal-title":"Neuroscientist"},{"key":"2837_CR54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2353\/ajpath.2008.070829","volume":"172","author":"JA Fein","year":"2008","unstructured":"Fein JA, Sokolow S, Miller CA, Vinters HV, Yang F, Cole GM, et al. Co-localization of amyloid beta and tau pathology in Alzheimer\u2019s disease synaptosomes. Am J Pathol. 2008;172:1683\u201392.","journal-title":"Am J Pathol"},{"key":"2837_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40035-021-00270-1","volume":"10","author":"M Wu","year":"2021","unstructured":"Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, et al. The role of pathological tau in synaptic dysfunction in Alzheimer\u2019s diseases. Transl Neurodegener. 2021;10:45.","journal-title":"Transl Neurodegener"},{"key":"2837_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42295-2","volume":"14","author":"Z Shen","year":"2023","unstructured":"Shen Z, Sun D, Savastano A, Varga SJ, Cima-Omori MS, Becker S, et al. Multivalent Tau\/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density. Nat Commun. 2023;14:6839.","journal-title":"Nat Commun"},{"key":"2837_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1021\/acs.jproteome.1c00865","volume":"21","author":"T Zhang","year":"2022","unstructured":"Zhang T, Fassl A, Vaites LP, Fu S, Sicinski P, Paulo JA, et al. Interrogating kinase-substrate relationships with proximity labeling and phosphorylation enrichment. J Proteome Res. 2022;21:494\u2013506.","journal-title":"J Proteome Res"},{"key":"2837_CR58","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","volume":"163","author":"S Muralidar","year":"2020","unstructured":"Muralidar S, Ambi SV, Sekaran S, Thirumalai D, Palaniappan B. Role of tau protein in Alzheimer\u2019s disease: the prime pathological player. Int J Biol Macromol. 2020;163:1599\u2013617.","journal-title":"Int J Biol Macromol"},{"key":"2837_CR59","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/mp.2017.218","volume":"23","author":"S Hunter","year":"2018","unstructured":"Hunter S, Brayne C. Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease. Mol Psychiatry. 2018;23:81\u201393.","journal-title":"Mol Psychiatry"},{"key":"2837_CR60","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.actbio.2022.11.010","volume":"155","author":"A Aliyandi","year":"2023","unstructured":"Aliyandi A, Reker-Smit C, Zuhorn IS, Salvati A. Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells. Acta Biomater. 2023;155:507\u201320.","journal-title":"Acta Biomater"},{"key":"2837_CR61","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1074\/mcp.M113.031716","volume":"13","author":"F Pischedda","year":"2014","unstructured":"Pischedda F, Szczurkowska J, Cirnaru MD, Giesert F, Vezzoli E, Ueffing M, et al. A cell surface biotinylation assay to reveal membrane-associated neuronal cues: Negr1 regulates dendritic arborization. Mol Cell Proteomics. 2014;13:733\u201348.","journal-title":"Mol Cell Proteomics"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02837-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02837-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T10:00:21Z","timestamp":1747735221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-024-02837-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2837"],"URL":"https:\/\/doi.org\/10.1038\/s41380-024-02837-6","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}